ムラガキ ヨシヒロ   MURAGAKI Yoshihiro
  村垣 善浩
   所属   研究施設 研究施設
   職種   教授
論文種別 原著
言語種別 英語
査読の有無 査読あり
表題 Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
掲載誌名 正式名:Journal of neurosurgery
略  称:J Neurosurg
ISSNコード:00223085
巻・号・頁 121(3),543-553頁
著者・共著者 ISHIKAWA Eiichi†, MURAGAKI Yoshihiro, YAMAMOTO Tetsuya, MARUYAMA Takashi, TSUBOI Koji, IKUTA Soko, HASHIMOTO Koichi, UEMAE Youji, ISHIHARA Takeshi, MATSUDA Masahide, MATSUTANI Masao, KARASAWA Katsuyuki, NAKAZATO Yoichi, ABE Tatsuya, OHNO Tadao, MATSUMURA Akira
発行年月 2014/09
概要 Temozolomide (TMZ) may enhance antitumor immunity in patients with glioblastoma multiforme (GBM). In this paper the authors report on a prospective Phase I/IIa clinical trial of fractionated radiotherapy (FRT) concomitant with TMZ therapy, followed by treatment with autologous formalin-fixed tumor vaccine (AFTV) and TMZ maintenance in patients with newly diagnosed GBM.
DOI 10.3171/2014.5.jns132392
文献番号 24995786